1205 related articles for article (PubMed ID: 20877280)
41. Social inequality, scientific inequality, and the future of mental illness.
Dean CE
Philos Ethics Humanit Med; 2017 Dec; 12(1):10. PubMed ID: 29258528
[TBL] [Abstract][Full Text] [Related]
42. Casting a wider fish net on animal models in neuropsychiatric research.
Hall ZJ; De Serrano AR; Rodd FH; Tropepe V
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Dec; 55():7-15. PubMed ID: 24726811
[TBL] [Abstract][Full Text] [Related]
43. Animal models of depression and anxiety: What do they tell us about human condition?
Neumann ID; Wegener G; Homberg JR; Cohen H; Slattery DA; Zohar J; Olivier JD; Mathé AA
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1357-75. PubMed ID: 21129431
[TBL] [Abstract][Full Text] [Related]
44. Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.
Sethi S; Brietzke E
Int J Neuropsychopharmacol; 2015 Oct; 19(3):pyv096. PubMed ID: 26453695
[TBL] [Abstract][Full Text] [Related]
45. Zebrafish Tools for Deciphering Habenular Network-Linked Mental Disorders.
Bühler A; Carl M
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672636
[TBL] [Abstract][Full Text] [Related]
46. Disrupted-in-schizophrenia-1 (DISC1): a key susceptibility factor for major mental illnesses.
Sawamura N; Sawa A
Ann N Y Acad Sci; 2006 Nov; 1086():126-33. PubMed ID: 17185511
[TBL] [Abstract][Full Text] [Related]
47. Basic concepts of neurotransmission.
Patel DR; Feucht C
Pediatr Clin North Am; 2011 Feb; 58(1):21-31, ix. PubMed ID: 21281846
[TBL] [Abstract][Full Text] [Related]
48. Perinatal Nutrition and Programmed Risk for Neuropsychiatric Disorders: A Focus on Animal Models.
DeCapo M; Thompson JR; Dunn G; Sullivan EL
Biol Psychiatry; 2019 Jan; 85(2):122-134. PubMed ID: 30293647
[TBL] [Abstract][Full Text] [Related]
49. Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders.
Choi SY; Pang K; Kim JY; Ryu JR; Kang H; Liu Z; Kim WK; Sun W; Kim H; Han K
Mol Brain; 2015 Nov; 8(1):74. PubMed ID: 26572867
[TBL] [Abstract][Full Text] [Related]
50. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
51. Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders.
Sarnyai Z; Guest PC
Adv Exp Med Biol; 2017; 974():97-114. PubMed ID: 28353227
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.
Alural B; Genc S; Haggarty SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():87-103. PubMed ID: 27072377
[TBL] [Abstract][Full Text] [Related]
53. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology.
McCarroll SA; Hyman SE
Neuron; 2013 Oct; 80(3):578-87. PubMed ID: 24183011
[TBL] [Abstract][Full Text] [Related]
54. Mice that lack the C-terminal region of Reelin exhibit behavioral abnormalities related to neuropsychiatric disorders.
Sakai K; Shoji H; Kohno T; Miyakawa T; Hattori M
Sci Rep; 2016 Jun; 6():28636. PubMed ID: 27346785
[TBL] [Abstract][Full Text] [Related]
55. Amine precursor therapy: manipulation of brain amine activity with precursor amino acid.
Nakajima T
Psychiatry Clin Neurosci; 1997 Oct; 51(5):267-74. PubMed ID: 9413872
[TBL] [Abstract][Full Text] [Related]
56. Role of DISC1 in Neuronal Trafficking and its Implication in Neuropsychiatric Manifestation and Neurotherapeutics.
Tomoda T; Hikida T; Sakurai T
Neurotherapeutics; 2017 Jul; 14(3):623-629. PubMed ID: 28664299
[TBL] [Abstract][Full Text] [Related]
57. Neurexins and neuropsychiatric disorders.
Kasem E; Kurihara T; Tabuchi K
Neurosci Res; 2018 Feb; 127():53-60. PubMed ID: 29221905
[TBL] [Abstract][Full Text] [Related]
58. [The impact of molecular biology on psychiatric diseases].
Salín-Pascual RJ; Alcocer Castillejos N
Rev Invest Clin; 2003; 55(2):216-9. PubMed ID: 12827930
[No Abstract] [Full Text] [Related]
59. Revitalizing psychiatric therapeutics.
Hyman SE
Neuropsychopharmacology; 2014 Jan; 39(1):220-9. PubMed ID: 24317307
[TBL] [Abstract][Full Text] [Related]
60. Imaging genetics for neuropsychiatric disorders.
Meyer-Lindenberg A; Zink CF
Child Adolesc Psychiatr Clin N Am; 2007 Jul; 16(3):581-97. PubMed ID: 17562580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
